School Of Medicine Basic Sciences

Meet Josh Luffman, construction and project manager in the facilities, infrastructure and risk management group within the School of Medicine Basic Sciences. Read More

The Center for Computational Systems Biology hosted its inaugural Symposium on AI, Spatial & Systems Biology. The two-day event highlighted how emerging 3D artificial intelligence technologies are transforming biomedical research, ushering in a new era of discovery that bridges molecular, cellular, and systems-level understanding of biology. Read More

Bingshan Li and his lab are changing the paradigm of how geneticists can identify risk genes for schizophrenia, enabling new studies into its underlying biology and opening new doors for the development of treatments against it. Read More

Shan Meltzer has been awarded a prestigious Edward Mallinckrodt, Jr. Foundation Award to advance her pioneering research on determining how the body’s sensory circuits form and function. Meltzer’s research could ultimately lead to new ways to rewire and repair sensory circuits to treat somatosensory disorders such as chronic pain, nerve injuries, and spinal cord injuries. Read More

Congratulations to our School of Medicine Basic Sciences faculty members who were promoted or received new appointments between July and September 2025. These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

In a heartwarming tribute to a remarkable career, more than 70 of his former graduate students and postdoctoral scholars recently traveled from across the globe for a three-day festivity on Oct. 3–5 to celebrate Larry Marnett’s 50 years in academia. Read More

Tune in to Professor of Biochemistry Chuck Sanders' yearly Halloween interview, this year featuring Maud Menten, co-creator of the Michaelis-Menten enzyme kinetics equation. Read More

In a heartwarming tribute to a remarkable career, more than 70 of his former graduate students and postdoctoral scholars recently traveled from across the globe for a three-day festivity on Oct. 3–5 to celebrate Larry Marnett’s 50 years in academia. Read More

Vanderbilt’s Dr. Benjamin P. Brown is improving the way the field of drug discovery creates machine learning algorithms to predict a protein’s interactions with a small molecule. These improvements bring ML closer to fulfilling its potential in the field—something that has not been realized after more than a decade of work. Read More

Vanderbilt researchers led by Ann Richmond have identified a promising drug combination that targets three key pathways in advanced melanoma, potentially restoring the immune response in patients resistant to standard immunotherapy. Although the work is preclinical, the use of drugs already in clinical trials for other conditions could accelerate testing in humans. Read More